Official Title
Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19
Brief Summary

Patients with neurological or psychiatric symptoms or pre-existing disease will be sampled (blood for serum and DNA or saliva for DNA) at inclusion and at M6 (blood) and M12 (blood) depending on their pathology. Sampling will be done either at hospital if patient is on site for routine care or at home if no consultation is scheduled at hospital.

Unknown status
COVID19
Neurologic Manifestations
Psychiatric Manifestations

Other: blood sample

blood sample for serum (serology, biomarkers) and DNA

Eligibility Criteria

1. Age over 18 yo

2. Patient having presented or presenting a Covid-19 infection defined by a positive PCR
or a typical chest scanner of Covid-19 infection or a positive serology or a typical
clinical picture in a pandemic period

3. And patient with:

1. a neurological or psychiatric manifestation de novo during or after the Covid-19
infection and/or

2. either a chronic neurological or psychiatric pathology

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Hôpital Pitié Salpétrière
Paris, France

Investigator: Céline LOUAPRE, MD
Contact: 1 42 16 57 66
celine.louapre@aphp.fr

Investigator: Céline LOUAPRE, MD

Contacts

Céline LOUAPRE, MD
1 42 16 57 66 - +33
celine.louapre@aphp.fr

Jean-Christophe CORVOL, MD,PHD
1 42 16 57 66 - +33
jean-christophe.corvol@aphp.fr

Brain & Spine Institute (ICM)
NCT Number
Keywords
Covid-19
Neurological disease
Multiple Sclerosis
psychiatric disease
biology,
biocollection,
biomarkers,
DNA,
Parkinson's Disease
MeSH Terms
COVID-19
Nervous System Diseases
Neurologic Manifestations